Correlation Between Milestone Pharmaceuticals and Ensysce Biosciences
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Ensysce Biosciences, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Ensysce Biosciences.
Diversification Opportunities for Milestone Pharmaceuticals and Ensysce Biosciences
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and Ensysce is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Ensysce Biosciences go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Ensysce Biosciences
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.39 times more return on investment than Ensysce Biosciences. However, Milestone Pharmaceuticals is 2.56 times less risky than Ensysce Biosciences. It trades about 0.36 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about -0.01 per unit of risk. If you would invest 145.00 in Milestone Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 54.00 from holding Milestone Pharmaceuticals or generate 37.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Ensysce Biosciences
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Ensysce Biosciences |
Milestone Pharmaceuticals and Ensysce Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Ensysce Biosciences
The main advantage of trading using opposite Milestone Pharmaceuticals and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.The idea behind Milestone Pharmaceuticals and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Ensysce Biosciences vs. Tff Pharmaceuticals | Ensysce Biosciences vs. Eliem Therapeutics | Ensysce Biosciences vs. Inhibrx | Ensysce Biosciences vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |